AspirinCyclooxygenase 2Cyclooxygenase InhibitorsCyclooxygenase 1Anti-Inflammatory Agents, Non-SteroidalCyclooxygenase 2 InhibitorsProstaglandin-Endoperoxide SynthasesIndomethacinIbuprofenDinoprostoneNaproxenProstaglandinsDiclofenacIsoenzymesSulfonamidesThromboxane B2PyrazolesNitrobenzenesPlatelet Aggregation InhibitorsArachidonic AcidPiroxicamLipoxygenase InhibitorsThiazinesSulindacSulfonesAcetaminophenSalicylatesLactonesKetoprofenMembrane ProteinsGastrointestinal DiseasesEpoprostenolArachidonic AcidsPlatelet Aggregation6-Ketoprostaglandin F1 alphaStomach UlcerThromboxane A2Dose-Response Relationship, DrugLipoxygenaseFlurbiprofenThromboxanesEicosanoidsAnalgesics, Non-NarcoticBlood PlateletsGastrointestinal HemorrhageTiclopidineGastric MucosaMasoprocolSodium SalicylateDrug Therapy, CombinationMeclofenamic AcidKetorolacThromboxane-A SynthaseEtodolacPlatelet Function TestsProstaglandin AntagonistsDrug InteractionsAsthma, Aspirin-InducedPeptic UlcerReceptors, Prostaglandin EHydroxyeicosatetraenoic AcidsIntramolecular OxidoreductasesOsteoarthritisArachidonate 5-LipoxygenaseRisk FactorsNitric OxideDinoprostProstaglandins EProstaglandins GSeminal VesiclesTolmetinTime FactorsPeptic Ulcer Hemorrhage4,5-Dihydro-1-(3-(trifluoromethyl)phenyl)-1H-pyrazol-3-amine5,8,11,14-Eicosatetraynoic AcidDouble-Blind MethodCells, CulturedLipoxinsAnticarcinogenic AgentsRats, Sprague-DawleyAnti-Inflammatory AgentsVasodilationEnzyme InhibitorsArthritisNitric Oxide SynthaseEndothelium, VascularRNA, MessengerFibrinolytic AgentsTablets, Enteric-CoatedEnzyme InductionChemopreventionLeukotrienesDrug HypersensitivitySafety-Based Drug WithdrawalsGene Expression Regulation, EnzymologicPlatelet ActivationRats, WistarTreatment OutcomeAnticoagulantsReceptors, Thromboxane